ArticleEndocrine oncology (Bristol, England)2024

Tolerability and outcomes of neuroendocrine tumors treated with PRRT and SBRT.

Jose E Nunez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.